JTM

official impact factor 3.51

Open Access Highly Access

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream

Abel Torres, Leslie Storey, Makala Anders, Richard L Miller, Barbara J Bulbulian, Jizhong Jin, Shalini Raghavan, James Lee, Herbert B Slade and Woubalem Birmachu*

Journal of Translational Medicine 2007, 5:7 doi:10.1186/1479-5876-5-7

Accesses  

  • Last 30 days: 99 accesses
  • Last 365 days: 987 accesses
  • All time: 8071 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists

Woubalem Birmachu, Raymond M Gleason, Barbara J Bulbulian, Christie L Riter, John P Vasilakos, Kenneth E Lipson, Yuri Nikolsky BMC Immunology 2007, 8:26 (12 October 2007)

Instrumental in TLR7-mediated amplification of the innate response, plasmacytoid dendritic cells increase expression of a variety of type I interferons (IFNs) and IFN-inducible genes and activate specific anti-viral signaling pathways when stimulated with TLR7 agonists.

Research   Open Access

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

Monica C Panelli, Mitchell E Stashower, Herbert B Slade, Kina Smith, Christopher Norwood, Andrea Abati, Patricia Fetsch, Armando Filie, Shelley-Ann Walters, Calvin Astry, Eleonora Aricó, Yingdong Zhao, Silvia Selleri, Ena Wang, Francesco M Marincola Genome Biology 2007, 8:R8 (15 January 2007)

An analysis of basal cell carcinoma subjected to local application of imiquimod revealed that most transcripts stimulated by imiquimod involve the activation of cellular innate and adaptive immune-effector mechanisms.